Creating glycoside diversity through stereoselective carboboration of glycals Authors: Zhenpeng Shen, Yue Yu, Dong Wu, Zhisen Wei, Weiyu Kong, Yangyang Li, Guoyin Yin Published: 2024 ABSTRACT AbstractSite-specific modification of glycosides to enhance or alter the physiological properties of the parent molecule has become a highly attractive strategy in drug development. However, creating glycoside building blocks with multiple diversifiable positions from readily available sugar precursors remains a challenging task. Herein, we present a highly regio- and stereoselective nickel-catalyzed carboboration of glycals, which offers a platform for generating glycoside diversity with diverse C1 and C2 modification potential. Specially, the integration of a readily modifiable boronate group at the C2 position markedly amplifies the versatility of this approach, furnishing a universal method for swiftly generating diverse rare sugars with C2-site modifications through expedited downstream transformations. This method demonstrates a broad substrate scope and tolerates various functional groups and complex natural or drug molecular architectures. Moreover, we illustrate the synthetic potential of this method through the synthesis of a diverse array of analogs of both natural products and pharmaceuticals.Subject terms: Homogeneous catalysis, Carbohydrate chemistry Introduction Glycosides constitute an essential class of compounds that exert pivotal influence across diverse biological, medicinal, and material chemistry realms1–4. These compounds, categorized into C-, O-, N-, and S-glycosides based on distinct linkages, occupy a central position in research due to their multifaceted roles5,6. However, certain glycoside compounds, derived from natural products, often display limited biological activity, falling short of the requirements in contemporary medicinal chemistry research7. As a result, there is a rising inclination among chemists and medicinal chemists for obtaining site-specific glycosides8,9. This preference stems from the potential of even modest structural alterations to produce compounds with heightened biological efficacy or entirely novel pharmacological properties10,11. For instance, a significant case involves the natural O-glycoside KRN7000, which was transformed into a C-glycoside variant, resulting in a remarkable 1000-fold increase in antimalarial activity compared to its precursor12 (Fig. 1a top). Another example is the deletion of an oxygen atom in the natural product phlorizin to generate a C-aryl glucoside13,14, which exhibits about 32-fold greater potency than phlorizin against SGLT215 (Fig. 1a middle). These results demonstrate that the exploration of biologically active molecules featuring C-glycoside motifs has emerged as a prominent avenue within the pharmaceutical research landscape, owing to their heightened hydrolytic stability in vivo compared to other glycoside types. This attribute significantly enhances their potential utility in drug discovery endeavors16. In addition to the C1 modification of glycosides, the C2 modification poses significant challenges while also holding immense potentials17–19. For example, clofarabine showed activity in human tumor xenograft models and demonstrated both hydrolytic stability and enhanced resistance to phosphorylase cleavage, attributed to C2 fluorination17 (Fig. 1a bottom). Therefore, developing methods for creating novel glycoside diversity would greatly benefit the drug discovery. Introducing the multi-site modification in carbohydrate chemistry. a Importance of site modification in carbohydrate chemistry. b Multi-site modification in carbohydrate chemistry. c 1,2-stereoselective carboboration of glycals. Over the past few decades, tremendous progress has been made toward C1 modification of glycosides20–22. These synthetic strategies encompass ionic pathway glycosylation (glycosyl cation and anion)23, radical pathway glycosylation24–27, and glycosylation involving transition-metal complexes28–30 (Fig. 1b). The rapid evolution of these methods has significantly broadened the substrate scope and diversified the range of rare sugars, thereby enhancing the platform for drug discovery. Moreover, the exploration into modifications at C2 position has also been succeeded by a radical 1,2-spin-center shift strategy31–34. Flexible modification of glycosides at dual positions provides great space for enriching the glycoside library35–37. They mainly rely on cumbersome synthesis from basic substrates, with often restricted stereocontrol and general applicability38–41. Therefore, developing straightforward processes using readily available sugars as substrates to achieve specific stereo control for C1 and C2 dual-site modifications is highly desirable and challenging42–44. Building upon our previous success in nickel-catalyzed a series of carboboration of alkenes45–48, we report a nickel-catalyzed regio- and stereoselective carboboration of glycals, employing commercially available 2-aminocyclohexanol as a ligand. This reaction yields a wide range of C2 position boron-containing C-glycosides with exclusive stereoselectivity and extensive tolerance to various functional groups. Through various simple and efficient transformations, diverse rare sugars could be obtained (Fig. 1c). Results Reaction development We initiated the carboboration reaction by choosing commercially available glycal (1a), B2pin2 (2), and benzyl bromide (3a) as model substrates (Fig. 2a). After extensive experimentation, we identified the combination of NiCl2·DME as the catalyst, 2-benzyloxy-cyclohexylamine (L1) as the ligand, LiOMe as the base, and N-methylpyrrolidone (NMP) as the solvent, conducted at 30 °C, as the optimal reaction condition. The carboboration product 4a was isolated in 89% yield with exclusive regio- and stereoselectivity under these conditions (entry 1). Subsequently, other ethanolamine skeleton ligands were also investigated. No significant influence on stereoselectivity was observed when using its enantiomer L2 (entry 2). This result suggests that the absolute configuration of the ligand does not affect the stereochemistry of this reaction. However, only trace amounts of product were obtained when utilizing unprotected 2-aminocyclohexanol (L3) or N-methylated aminocyclohexanol (L4) or 2-benzyloxy-cyclohexylamine (L5), respectively, indicating the importance of the free alcohol and the benzyl group on the ligand for this transformation (entries 3–5). When ligands L6–L8 were used, the yield decreased, while the regioselectivity and stereoselectivity remained unchanged (entries 6-8). Notably, those nitrogen ligands frequently used in nickel catalysis were proved no reactivity at all, indicating the challenge inherent in this reaction (see Supplementary Table 1). Moreover, switching NiCl2·DME to other nickel salts led to decreased reactivity (entries 9-10). Various solvents were also investigated, with amide solvents proving favorable for the reaction (entries 11–13). Control experiments demonstrated the indispensability of both ligand and catalyst for this transformation (entries 14–15). Optimization of reaction conditions and proposed catalytic cycle. a Optimization of reaction conditions. b Proposed catalytic cycle. aReaction conditions: NiCl2·DME (5 mol%), L (5 mol%), 1a (0.2 mmol, 1.0 equiv.), 2 (2.0 equiv.), 3a (2.0 equiv.), LiOMe (3.0 equiv.) and NMP (1.0 mL), stirred at 30 °C for 20 h. Yields were determined by GC using naphthalene as an internal standard, regioselectivity ratios (rr) were determined by GC analysis of the crude reaction mixture. Based on previous literature and our findings, we propose a possible mechanism. As illustrated in Fig. 2b, first, Ni(II) halide I undergoes transmetallation with B2pin2 in the presence of a ligand and base, generating Ni(II)-Bpin species II. Next, the glycal undergoes migratory insertion to form a sugar-based alkyl nickel(II) species IV. This species then reacts with an alkyl radical to produce alkyl nickel(III) species V, which subsequently undergoes reductive elimination to yield the 1,2-cis target product. Meanwhile, the generated Ni(I) species reacts with an alkyl halide via halogen transfer, creating an alkyl radical and regenerating Ni(II) halide. Substrate scope With optimal conditions established, we then explored the substrate scope of the nickel-catalyzed 1,2-cis-carboboration of glycals. As depicted in Fig. 3, para-substituted benzyl bromides, encompassing both electron-withdrawing and electron-donating groups such as trifluoromethoxy (4b), trifluoromethyl (4c), ester (4d), cyano (4e), and phenyl (4f), were well tolerated under standard conditions. This resulted in the formation of corresponding products in yields ranging from 59% to 87%, exhibiting exclusive regioselectivity and stereoselectivity. Additionally, reactions involving benzyl bromides bearing other substituents, such as boronic ester (4g) and bromide (4h and 4i), yielded satisfactory outcomes, thus paving the way for further downstream cross-coupling endeavors. Furthermore, multisubstituted substrates demonstrated good compatibility within the reaction system, furnishing the desired products 4k–4m in yields of 65−87%. Subsequently, our focus shifted to unactivated alkyl electrophiles. Various alkyl halides featuring aryl (4o), adamantyl (4p), chloride (4q), amine (4r and 4s), ester (4t and 4u), cyano (4v), boronic ester (4w), silyl ether (4x), alcohol (4ab) substituents were successfully incorporated into the reaction, yielding 1,2-cis-carboboration products with broad functional group tolerance. The absolute configuration of the products was unambiguously confirmed via X-ray crystallographic analysis of 4aa. We believe that this class of boronated glycosides, possessing diverse functional groups on their alkyl chains, holds potential applications in drug development, biology and materials science owing to their versatility and convertibility. Moreover, secondary alkyl halides exhibiting significant steric hindrance (4ac-4ad) underwent the reaction successfully, yielding the corresponding products with moderate isolated yields and exclusive stereoselectivity. Importantly, the addition of a bromide salt to promote halide exchange proved crucial for the success of reactions involving alkyl iodides. Reaction scope of alkyl electrophiles. aReaction conditions: NiCl2·DME (5 mol%), L1 (5 mol%), glycals (0.4 mmol, 1.0 equiv.), B2pin2 (2.0 equiv.), benzyl bromides or alkyl halides (2.0 equiv.), LiOMe (3.0 equiv.) and NMP (2.0 mL), stirred at 50 °C for 20 h. b30 °C was used. cAddition of MgBr2•Et2O (1.0 equiv.). We then shifted our focus to explore the versatility of glycals. As depicted in Fig. 4, various protecting groups such as Bn- (4ae) and TBS- (4af) were effectively accommodated in the nickel-catalyzed 1,2-cis-carboboration, yielding moderate to good yields alongside exclusive stereoselectivity. Noteworthy is the successful conversion of glycals featuring unprotected primary alcohols or with an acyl group derived from oxaprozin at the C6 position into the target products (4ag, 4al) with high yields and exclusive stereoselectivity, however, the glycal containing all free hydroxyl groups or with all peracetylated, the anticipated carboboration products were not observed (4ap, 4aq). This discrepancy could potentially be attributed to the presence of multiple hydroxyl or ester groups, which might coordinate with the nickel species, subsequently deactivating the nickel catalyst. Furthermore, glycal protected with an aldehyde group could also furnish carboboration product (4ah) with exclusive stereoselectivity. Concurrently, substrates derived from galactals were successfully transformed into the corresponding carboboration products (4ai-4al), and the absolute configuration was assigned by X-ray crystallographic analysis of product 4aj. Notably, when the D-arabinal-derived glycal is employed, we are able to obtain 1,2-cis-β-C-glycosides with a moderate yield and outstanding stereoselectivity (4am-4ao). These results indicating that the stereochemistry of this reaction is influenced by the C3 substituent, and this variation occurs during the migratory insertion step, which takes place on the face opposite to the C3 substituent. Furthermore, to underscore the synthetic advantage of this chemistry in late-stage applications, a variety of natural products and drug glycoconjugates were subjected to the standardized conditions (Fig. 4). These include the nature product D-ribonic acid (4ar), the anti-acne drug adapalene (4as), the anti-inflammatory drug ibuprofen (4at), oxaprozin (4au) and the uricosuric agent probenecid (4av). This significantly broadens the substrate scope and highlights its potential in preparing complex medicinally relevant compounds. Reaction scope of glycals and biorelevant derivatives. Reaction conditions: NiCl2·DME (5 mol%), L1 (5 mol%), glycals (0.4 mmol, 1.0 equiv.), B2pin2 (0.8 mmol, 2.0 equiv.), benzyl bromide or alkyl bromide (0.8 mmol, 2.0 equiv.), LiOMe (3.0 equiv.) and NMP (2.0 mL), stirred at 50 °C for 20 h. To our surprise, when aryl bromides were used as coupling partners for the carboboration of glycals, we were able to obtain both 1,2- and 2,1-regioisomers by adjusting the optimal reaction conditions (see Supplementary Tables 2-3). As shown in Fig. 5, both catalytic systems exhibited moderate yields and excellent regioselectivities. The absolute configurations were determined by X-ray crystallographic analysis of products 6c and 7c. Notably, our method allowed for the efficient synthesis of several important commercial drug analogs for the treatment of type 2 diabetes, with simultaneous modification of both the C1 and C2 positions of the glycoside (6d-6g, 7d-7g). These boron-containing analogs offer greater potential for diversification, thereby expanding the library of bioactive molecules. Control experiments (see Supplementary Figs. 1-2) suggest that 1,2-arylboration likely occurs through the formation of Ni(II)Bpin species, followed by glycal insertion, whereas 2,1-arylboration is attributed to the formation of Ni(II)Ar species, also followed by glycal insertion49,50. The role of the ligand in controlling regioselective arylboration remains under investigation in our laboratory. Regiodivergent arylboration. a1,2-cis arylboration reaction conditions: NiCl2·DME (5 mol%), L8 (5 mol%), glycals (0.4 mmol, 1.0 equiv.), B2pin2 (2.0 equiv.), aryl bromide (2.0 equiv.), LiOMe (3.0 equiv.) and MTBE (2.0 mL), stirred at 50 °C for 20 h. b2,1-cis arylboration reaction conditions: NiCl2·DME (5 mol%), glycals (0.4 mmol, 1.0 equiv.), B2pin2 (2.0 equiv.), aryl bromide (2.0 equiv.), LiOMe (3.0 equiv.) and CPME(2.0 mL), t-BuOH (1.0 mL) stirred at 50 °C for 20 h. Synthetic applications To further showcase the synthetic potential of this reaction, a series of stereoselective transformations of the boronate group in the representative product 4a were conducted. As outlined in Fig. 6a, a gram-scale experiment with 10 mmol was initially performed, producing 4a with a slightly lower yield but still exclusive regio- and stereoselectivity, highlighting the scalability and practicality of this transformation. Subsequently, the C2-unprotected glycoside (8) was obtained after oxidation. Furthermore, compound 8 was stereo-inversely converted to 9 via a Mitsunobo reaction with phthalimide. A primary boronate ester (10) was synthesized through Matteson homologation51. Furthermore, employing a Matteson homologation followed by two oxidation steps, a C-glycoside containing a free carboxyl acid group at C2 position was produced (11). Furthermore, we have integrated two drug molecule fragments into the glycals to create a promising bioactive compound, designated as product 12. In addition to modifying the C2 position, we utilized our chemical approach to synthesize analog of the natural product α-arbutin (13) known for its whitening activity52 (Fig. 6b). Specifically, we obtained α-benzyl-glycoside (14), where an oxygen atom within α-arbutin is transformed into a carbon atom through oxidation and TABF debenzylation sequences. These results underscore the versatility of this method for the synthesis of diverse glycoside compounds. Additionally, the incorporation of boron groups into C-glycoside molecules was first explored as a potential agent (15) for Boron Neutron Capture Therapy (BNCT) in cancer treatment53–55. Building upon this concept, we synthesized an analog of a C-glycoside BNCT agent (16) using this chemistry56–58, followed by DDQ deprotection (Fig. 6c). Finally, utilizing our method, we successfully synthesized key intermediate 17, facilitating the construction of C-glycosidic solid-phase peptide synthesis (SPPS) building blocks 18 (Fig. 6d)59. Transformations of products and synthetic applications. a Representative transformation of the product. b Synthetic natural product derivatives. c Synthesis of potential BNCT agent analog. d Synthesis of C-glycoside SPPS building block. Discussion In summary, we have successfully achieved the simultaneous modification of both the C1 and C2 positions of glycoside, enabling the concise synthesis of 2-boryl-C-glycosides with exceptional stereoselective control60,61. Our method allows for the coupling of a wide range of C(sp3) and C(sp2) carbon-based electrophiles under mild reaction conditions. Notably, it achieves ligand-controlled regiodivergent arylboration of glycals. Moreover, this approach provides an avenue for C2 diversification of glycosides through downstream transformations of boronate esters in the C2 position. Additionally, our methodology has demonstrated its synthetic utility by enabling the concise synthesis of bioactive molecule analogs, which hold promise for applications in drug discovery. We anticipate that this method will serve as a versatile synthetic platform, facilitating the enrichment of diverse glycoside libraries and advancing the field of medicinal chemistry. Methods Model procedure Under N2 atmosphere, an oven-dried 10 mL reaction tube which equipped with a magnetic stir bar and sealed with a rubber stopper sequentially was added NiCl2·DME (4.4 mg, 0.02 mmol, 5 mol%), L (4.2 mg, 0.02 mmol, 5 mol%), MeOLi (45.6 mg, 1.2 mmol, 3.0 equiv.) and bis(pinacolato)diboron (203.2 mg, 0.8 mmol, 2.0 equiv.). Then anhydrous solvent (2.0 mL), glycals (0.4 mmol, 1.0 equiv.), halides (0.8 mmol, 2.0 equiv.) were added, and the mixture was stirred. If alkyl iodide was used as an electrophilic reagent, the addition of the additive MgBr2·Et2O (0.4 mmol, 1.0 equiv.) can increase the yield. After 20 h of stirring at 30 °C, the resulting mixture was quenched with H2O (6.0 mL). Then the mixture was extracted with ethyl acetate and the combined organic layers were dried over anhydrous Na2SO4, filtered, and concentrated under vacuum. The crude material was separated on a silica gel column affording the desired product. Supplementary information Supplementary Information Transparent Peer Review file Acknowledgements National Natural Science Foundation of China (22122107) is acknowledged for financial support. We also thank the Core Facility of Wuhan University for providing the X-ray diffraction equipment. Author contributions G.Y.Y. and Y.Y.L. designed and supervised the project. Z.P.S. developed the catalytic method. Z.P.S., Y.Y., D.W., Z.S.W., and W.Y.K. supported the design and performance of synthetic experiments. All the authors were involved the analysis of results and discussions of the project. Peer review Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work. A peer review file is available. Data availability The authors declare that all other data supporting the findings of this study are available within the article and Supplementary Information files and can also be obtained from the corresponding author on request. Crystallographic data for the structures reported in this Article have been deposited at the Cambridge Crystallographic Data Center, under deposition numbers CCDC 2358531 (4aa), 2313827 (4aj), 2384779 (6c), 2384780 (7c). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information Yangyang Li, Email: yangyangl@whu.edu.cn. Guoyin Yin, Email: yinguoyin@whu.edu.cn. Supplementary information The online version contains supplementary material available at 10.1038/s41467-024-54016-4. References Associated Data Supplementary Materials Supplementary Information Transparent Peer Review file Data Availability Statement The authors declare that all other data supporting the findings of this study are available within the article and Supplementary Information files and can also be obtained from the corresponding author on request. Crystallographic data for the structures reported in this Article have been deposited at the Cambridge Crystallographic Data Center, under deposition numbers CCDC 2358531 (4aa), 2313827 (4aj), 2384779 (6c), 2384780 (7c). Copies of the data can be obtained free of charge via https://www.ccdc.cam.ac.uk/structures/.